2026 NOSCM | Selecting The Best Immunotherapy Option in First Line Metastatic NSCLC

2026 NOSCM | Selecting The Best Immunotherapy Option in First Line Metastatic NSCLC

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Jul 28, 2026
Last Review
Jul 28, 2026
Expires
Jul 28, 2029

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

Accreditation

N/A